Improving Outcomes in Rheumatoid Arthritis: Comparative Effectiveness of Current Treatments — On-demand CE/CME Webinar
A. Scott Mathis, PharmD
Monmouth Medical Center
Long Branch, NJ
Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, affects approximately 1% of the world population and is associated with considerable morbidity and health care costs. Fortunately, management of this daunting disease has been largely transformed from mere symptom control to disease control with disease-modifying antirheumatic drugs (DMARDs) and biologic agents. This activity is intended to provide a relevant discussion on epidemiology, pathophysiology, burden, and current management of RA. The focus of the treatment review will involve an analysis of comparative effectiveness of DMARDs and biologic agents. Also included is an examination of the impact of managed care and specialty pharmacy, as well as disease management programs, on the treatment of RA.
Upon completion of this educational activity, participants should be able to:
Intended audience: Medical directors, pharmacy directors, specialty pharmacists, and other managed care professionals who oversee the care of patients with rheumatoid arthritis.
Accreditation/Designation of credit
This activity has been planned and implemented in
accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Physicians’ Education Resource and Pharmacy Times Office of Continuing Professional Education. Physicians’ Education Resource is accredited by the ACCME to provide continuing medical education for physicians.
Physicians’ Education Resource designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Repurposing Statement: If you received credit for the live Webinar on December 13, 2012, please note that you will not receive credit for completing the enduring online Webinar. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will Physician’s Education Resource®, LLC (PER) award duplicate credit for the activity.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.1 CEU) under the ACPE universal activity number 0290-9999-12-094-H01-P.The activity is available for CE credit through December 20, 2013.
This activity is supported by an educational grant from Bristol-Myers Squibb.
Type of activity: Knowledge
Length of Webinar: 1-hour including question-and-answer session.
Release date: December 20, 2012
Expiration date: December 20, 2013
This CE lesson is contained in the following video/webinar formats:
This CE lesion is contained in the following PDF slides:
A transcript of the live webinar’s Q&A session is available in this downloadable file:
How to Obtain Credit
To receive your CE certificate, participants must view the entire activity online and complete the online post-test with a score of 70% or better. After successful completion of the online post-test, participants may immediately print their certificates.
A. Scott Mathis, PharmD, has no relevant financial relationships with commercial interests to disclose related to this activity.
American Journal of Managed Care
Planning Staff—Jeff D. Prescott, PharmD, RPh; Kara Guarini, MS; and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Office of Continuing Professional Education (PTOCPE)
Planning Staff—Judy V. Lum, MPA; Elena Beyzarov, PharmD; and Donna Fausak have no relevant financial relationships with commercial interests to disclose related to this activity.
PTOCPE uses an anonymous peer reviewer as part of content validation and conflict of interest resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose related to this activity.
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CE/CME activity, please contact: firstname.lastname@example.org.